Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:34 PM
Ignite Modification Date:
2025-12-24 @ 4:34 PM
NCT ID:
NCT02042066
Eligibility Criteria:
Inclusion Criteria:
* Subjects who have provided written informed consent.
* Age ≥18 and ≤80 years old.
* Office systolic blood pressure that remains ≥160 mmHg (≥150 mmHg for patient with type 2 diabetes) despite the stable use of ≥3 antihypertensive medications concurrently at maximally tolerated doses, of which one is a diuretic (unless there is a tolerance or a contraindication for a diuretics).
* Able and willing to comply with the required follow-up schedule.
Exclusion Criteria:
* Subjects who have participated in a clinical study involving another investigational drug or device within 4 weeks prior to Screening.
* Have hypertension secondary to an identifiable and treatable cause or take medication that can raise the BP.
* Prior renal artery intervention (balloon angioplasty or stenting).
* Pregnancy.
* Uncompensated heart failure.
* Chronic Liver Disease.
* Patients with skin wound / infection at the treatment area.
* Subjects who take oral anti-coagulants.
* Local tumor of treatment area.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02042066
Study Brief:
Protocol Section:
NCT02042066